QSTED
Pfizer Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75573361 |
| Registration Number | 2711603 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 2 |
| Attorney Name | Heather McDonald |
| Law Office Assigned | M60 |
| Employee Name | DEFORD, JEFFREY S |
Timeline
| 1998-10-19 | Application Filed |
| 1999-09-14 | Published for Opposition |
| 2002-10-04 | Date of First Use |
| 2003-04-29 | Trademark Registered |
| 2008-05-16 | Location: SCANNING ON DEMAND |
| 2009-12-05 | Cancelled |
| 2009-12-05 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Pfizer Inc. |
| Address | 235 East 42nd Street New York DE 10017 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical compound used to treat irritable bowel syndrome and incontinence |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1999-05-13 | 1 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1999-05-14 | 2 CNSA P: |
| NOTICE OF PUBLICATION | 1999-08-13 | 3 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1999-09-14 | 4 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 1999-12-07 | 5 NOAM O:Outgoing Correspondence |
| EXTENSION 1 FILED | 2000-04-20 | 6 EXT1 S: |
| EXTENSION 1 GRANTED | 2000-06-12 | 7 EX1G S: |
| EXTENSION 2 FILED | 2000-09-28 | 8 EXT2 S: |
| EXTENSION 2 GRANTED | 2000-12-12 | 9 EX2G S: |
| EXTENSION 3 FILED | 2001-04-16 | 10 EXT3 S: |
| EXTENSION 3 GRANTED | 2001-05-10 | 11 EX3G S: |
| EXTENSION 4 FILED | 2001-08-13 | 12 EXT4 S: |
| EXTENSION 4 GRANTED | 2001-12-07 | 13 EX4G S: |
| PAPER RECEIVED | 2002-03-25 | 14 MAIL I:Incoming Correspondence |
| EXTENSION 5 FILED | 2002-03-25 | 15 EXT5 S: |
| EXTENSION 5 GRANTED | 2002-04-05 | 16 EX5G S: |
| PAPER RECEIVED | 2002-12-09 | 17 MAIL I:Incoming Correspondence |
| USE AMENDMENT FILED | 2002-12-05 | 18 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2002-12-05 | 19 SUPC I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2003-03-03 | 20 DOCK D:Assigned to Examiner |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2003-03-06 | 21 CNPR P: |
| REGISTERED-PRINCIPAL REGISTER | 2003-04-29 | 22 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2008-02-27 | 23 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2008-02-27 | 24 ARAA I:Incoming Correspondence |
| CASE FILE IN TICRS | 2008-05-16 | 25 CFIT O:Outgoing Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2009-12-05 | 26 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 QSTED 85565180 not registered Dead/Abandoned |
Pfizer Products Inc. 2012-03-09 |
 QSTED 77554582 not registered Dead/Abandoned |
Pfizer Inc. 2008-08-25 |
 QSTED 75573361 2711603 Dead/Cancelled |
Pfizer Inc. 1998-10-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 